2,038
Views
4
CrossRef citations to date
0
Altmetric
Research paper

ANXA1 (Annexin A1) regulated by MYC (MYC proto-oncogene) promotes the growth of papillary thyroid carcinoma

, , ORCID Icon, , , & show all
Pages 9251-9265 | Received 30 Jul 2021, Accepted 16 Oct 2021, Published online: 27 Dec 2021

References

  • Seib CD, Sosa JA. Evolving understanding of the epidemiology of thyroid cancer. Endocrinol Metab Clin North Am. 2019;48(1):23–35.
  • Wu D, Hu S, Hou Y, et al. Identification of potential novel biomarkers to differentiate malignant thyroid nodules with cytological indeterminate. BMC Cancer. 2020;20(1):199.
  • Pinto N, Prokopec SD, Vizeacoumar F, et al. Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models. PLoS One. 2018;13(11):e0207152.
  • Sa R, Cheng L, Jin Y, et al. Distinguishing patients with distant metastatic differentiated thyroid cancer who biochemically benefit from next radioiodine treatment. Front Endocrinol (Lausanne). 2020;11:587315.
  • Lee HS, Lee JW, Park JH, et al. Comprehensive analysis for diagnosis of preoperative non-invasive follicular thyroid neoplasm with papillary-like nuclear features. PLoS One. 2019;14(7):e0218046.
  • Zajkowska K, Kopczynski J, Gozdz S, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a problematic entity. Endocr Connect. 2020;9(3):R47–R58.
  • Han PF, Che XD, Li HZ, et al. Annexin A1 involved in the regulation of inflammation and cell signaling pathways. Chin J Traumatol. 2020;23(2):96–101.
  • Liu A, Huang W, Zeng G, et al. Expression of the Annexin A1 gene is associated with suppression of growth, invasion and metastasis of nasopharyngeal carcinoma. Mol Med Rep. 2014;10(6):3059–3067.
  • Foo SL, Yap G, Cui J, et al. Annexin-A1 - A blessing or a curse in cancer? Trends Mol Med. 2019;25(4):315–327.
  • Sugimoto MA, Ribeiro ALC, Costa BRC, et al. Plasmin and plasminogen induce macrophage reprogramming and regulate key steps of inflammation resolution via annexin A1. Blood. 2017;129:2896–2907.
  • Zhao X, Ma W, Li X, et al. ANXA1 enhances tumor proliferation. and migration by regulating epithelial-mesenchymal transition and IL-6/JAK2/STAT3 pathway in papillary thyroid carcinoma. J Cancer. 2021;12:1295–1306.
  • Ciregia F, Giusti L, Molinaro A,et al. Presence in the pre-surgical fine-needle aspiration of potential thyroid biomarkers previously identified in the post-surgical one. PLoS One. 2013 Sep 2;8(9):e72911. doi:10.1371/journal.pone.0072911. PMID: 24023790; PMCID: PMC3759451
  • Elbadawy M, Usui T, Yamawaki H, et al. Emerging roles of C-Myc in cancer stem cell-related signaling and resistance to cancer chemotherapy: a potential therapeutic target against colorectal cancer. Int J Mol Sci. 2019;20. DOI:10.3390/ijms20092340
  • Da Costa EM, Armaos G, McInnes G, et al. Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation. J Exp Clin Cancer Res. 2019;38(1):251.
  • Sanjari M, Kordestani Z, Safavi M, et al. Enhanced expression of Cyclin D1 and C-myc, a prognostic factor and possible mechanism for recurrence of papillary thyroid carcinoma. Sci Rep. 2020;10(1):5100.
  • Zhang Y, Li F, Chen J. MYC promotes the development of papillary thyroid carcinoma by inhibiting the expression of lncRNA PAX8‑AS1:28. Oncol Rep. 2019;41:2511–2517.
  • Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–2504.
  • Prates J, Moreli JB, Gimenes AD, et al. Cisplatin treatment modulates Annexin A1 and inhibitor of differentiation to DNA 1 expression in cervical cancer cells. Biomed Pharmacother. 2020;129:110331.
  • Yuan Y, Anbalagan D, Lee LH, et al. ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and c-Myc to reduce breast cancer proliferation. Oncotarget. 2016;7(19):27007–27020.
  • Liu X, Xu J, Zhang B, et al. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications. Mol Cancer. 2019;18(1):184.
  • Blish CA. Natural Killer cell diversity in viral infection: why and how much? Pathog Immun. 2016;1(1):165–192.
  • Chen S, Liu M, Liang B, et al. Identification of human peripheral blood monocyte gene markers for early screening of solid tumors. PLoS One. 2020;15(3):e0230905.
  • Kovaleva OV, Rashidova MA, Samoilova DV, et al. Immunosuppressive phenotype of esophagus tumors stroma. Anal Cell Pathol (Amst). 2020;2020:5424780.
  • Kazdan J, Sharp V, Pui J. Case report: a rare presentation of high risk epithelioid hemangioendothelioma on leg treated with surgical excision. Int J Surg Case Rep. 2019;59:66–69.
  • Wang N, Wu D, Long Q, et al. Dysregulated YY1/PRMT5 axis promotes the progression and metastasis of laryngeal cancer by targeting Hippo pathway. J Cell Mol Med. 2020;25(2):946–959.